Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of CopycatsFDA's crackdown on cheap weight-loss drugs threatens access for many Americans, raising treatment costs.Compounded versions of Wegovy and Zepbound to be phased out as shortages are declared over.